Rapaflo and Breastfeeding
It is currently not known whether Rapaflo (silodosin) passes through breast milk. No clinical studies have been conducted on breastfeeding while taking Rapaflo, since the drug is not intended for use in women. Before taking this medication, breastfeeding women should consult their healthcare providers to discuss any potential risks.
At this time, it is not known if Rapaflo™ (silodosin) passes through breast milk. Therefore, if you are breastfeeding, you should talk with your healthcare provider about taking Rapaflo. It should be noted that Rapaflo is approved for treating an enlarged prostate and is not approved for any use in women.
No research has been done to see if Rapaflo passes through breast milk, since this medication is not intended for use in women. It is unknown whether it passes through breast milk, and it is unknown whether it could cause any problems in the breastfed infant. If your healthcare provider recommends that you take Rapaflo while breastfeeding, be sure to watch for any side effects in your child.
You should talk with your healthcare provider about Rapaflo and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Rapaflo and breastfeeding in your particular situation.